Everforth
EFOR
34.91
-1.06
-2.95%
Everforth
US · EFOR
#2997 by market cap
Listed 1970
34.91
-1.06
-2.95%
Live - 5344 symbols - heartbeat 406s ago
· 2026-10-08 07:00
Pre-market
34.90
-0.03%
After-hours
34.91
0.00%
Overnight
34.91
0.00%
- Market cap
- 1.43B
- P/E (TTM)i
- 17.99
- P/Bi
- 0.79
- EPSi
- 2.60
- Div yieldi
- 0.00%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on EFOR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.32, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -2.91% YoY
Margins
- Gross margin
- 28.87%
- Operating margin
- 5.79%
- Net margin
- 2.85%
Key ratios & quality
- Altman Z-Scorei
- 2.32
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.40B | 3.42B | 3.50B | 4.01B | 4.58B | 4.45B | 4.10B | 3.98B |
| Gross profit | 1.02B | 971.50M | 947.20M | 1.14B | 1.37B | 1.28B | 1.18B | 1.15B |
| Selling & admin expenses | 705.00M | 645.00M | 615.00M | 735.80M | 895.00M | 844.20M | 821.20M | 854.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 260.20M | 276.20M | 281.20M | 350.90M | 409.50M | 364.10M | 304.40M | 230.30M |
| Pretax profit | 204.20M | 204.40M | 241.50M | 313.40M | 363.60M | 297.70M | 240.10M | 162.60M |
| Tax | 46.20M | 54.70M | 63.90M | 81.60M | 96.70M | 78.40M | 64.90M | 49.10M |
| Net profit | 157.70M | 174.70M | 200.30M | 409.90M | 268.10M | 219.30M | 175.20M | 113.50M |
| Basic EPS | 3 | 3 | 4 | 8 | 5 | 5 | 4 | 3 |
| Diluted EPS | 2.98 | 3.28 | 3.76 | 7.66 | 5.23 | 4.50 | 3.83 | 2.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 968.30M | 1.02B | 1.01B | 980.10M | 968.30M | 1.01B |
| Gross profit | 275.40M | 293.30M | 296.90M | 283.50M | 266.60M | 284.60M |
| Selling & admin expenses | 214.50M | 216.80M | 212.20M | 210.50M | 224.40M | 226.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 46.60M | 59.60M | 67.90M | 56.20M | 27.70M | 41.10M |
| Pretax profit | 31.20M | 41.40M | 50.50M | 39.50M | 10.60M | 20.70M |
| Tax | 10.30M | 12.10M | 12.40M | 14.30M | 5.10M | 6.50M |
| Net profit | 20.90M | 29.30M | 38.10M | 25.20M | 5.50M | 14.20M |
| Basic EPS | 0 | 1 | 1 | 1 | 0 | 0 |
| Diluted EPS | 0.48 | 0.67 | 0.87 | 0.59 | 0.13 | 0.35 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 686.30M | 791.50M | 994.40M | 1.31B | 981.10M | 973.30M | 917.70M | 916.20M |
| Cash & ST investments | 41.80M | 95.20M | 274.40M | 529.60M | 70.30M | 175.90M | 205.20M | 161.20M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 2.69B | 2.94B | 3.28B | 3.50B | 3.59B | 3.54B | 3.43B | 3.68B |
| Total current liabilities | 308.20M | 340.90M | 416.20M | 450.90M | 441.90M | 394.10M | 367.10M | 424.30M |
| Short-term debt | -- | 25.80M | 24.30M | 23.30M | 22.90M | 19.50M | -- | -- |
| Long-term debt | 1.10B | 1.03B | 1.03B | 1.03B | 1.07B | 1.04B | 1.03B | 1.17B |
| Total liabilities | 1,505,700,000.00 | 1,565,200,000.00 | 1,690,900,000.00 | 1,637,400,000.00 | 1,684,400,000.00 | 1,652,500,000.00 | 1,652,300,000.00 | 1,873,300,000.00 |
| Total equity | 1.18B | 1.38B | 1.59B | 1.87B | 1.90B | 1.89B | 1.78B | 1.80B |
| Retained earnings | 586.10M | 744.70M | 926.30M | 1.17B | 1.20B | 1.20B | 1.10B | 1.09B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 879.60M | 916.30M | 918.40M | 916.20M | 970.30M | 987.60M |
| Cash & ST investments | 107.00M | 138.90M | 126.50M | 161.20M | 143.60M | 152.90M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.70B | 3.72B | 3.70B | 3.68B | 4.03B | 4.02B |
| Total current liabilities | 371.50M | 434.60M | 462.30M | 424.30M | 461.90M | 464.40M |
| Short-term debt | 19.80M | -- | -- | -- | -- | -- |
| Long-term debt | 1.28B | 1.21B | 1.17B | 1.17B | 1.46B | 1.44B |
| Total liabilities | 1,905,100,000.00 | 1,888,200,000.00 | 1,867,200,000.00 | 1,873,300,000.00 | 2,238,700,000.00 | 2,218,400,000.00 |
| Total equity | 1.79B | 1.83B | 1.83B | 1.80B | 1.79B | 1.81B |
| Retained earnings | 1.08B | 1.10B | 1.11B | 1.09B | 1.07B | 1.08B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 287.40M | 313.20M | 424.80M | 193.70M | 307.80M | 456.90M | 400.00M | 327.90M |
| Depreciation & amortization | 95.00M | 91.20M | 89.70M | 89.60M | 91.40M | 100.30M | 96.30M | 113.50M |
| Free cash flow | 258.70M | 280.50M | 392.20M | 159.00M | 270.30M | 417.00M | 364.70M | 288.10M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -20.00M | -27.90M | -181.30M | -281.40M | -273.10M | -327.20M | -170.10M |
| Ending cash balance | 41.80M | 95.20M | 274.40M | 529.60M | 70.30M | 175.90M | 205.20M | 161.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 16.80M | 124.90M | 83.90M | 102.30M | 18.50M | 52.20M |
| Depreciation & amortization | 25.60M | 28.70M | 29.30M | 29.90M | 28.00M | 31.20M |
| Free cash flow | 6.60M | 115.80M | 72.00M | 93.70M | 9.10M | 46.30M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -50.40M | -9.50M | -46.00M | -64.20M | -39.00M | -11.50M |
| Ending cash balance | 107.00M | 138.90M | 126.50M | 161.20M | 143.60M | 152.90M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 14.51 | 13.66 | 13.52 | 23.75 | 14.24 | 11.56 | 9.55 | 6.34 |
| ROA %i | 7.01 | 6.21 | 6.44 | 12.09 | 7.56 | 6.15 | 5.02 | 3.19 |
| ROIC %i | 10.45 | 8.87 | 8.80 | 15.42 | 10.08 | 8.91 | 7.56 | 5.51 |
| 5-year avg ROE %i | 13.82 | 14.13 | 14.08 | 16.48 | 15.93 | 15.34 | 14.52 | 13.09 |
| EBIT margin %i | 7.65 | 7.38 | 7.86 | 8.75 | 8.94 | 8.18 | 7.42 | 5.79 |
| FCF / sales %i | 7.61 | 7.15 | 9.93 | 3.97 | 5.90 | 9.37 | 8.90 | 7.24 |
| Current ratioi | 2.23 | 2.32 | 2.39 | 2.90 | 2.22 | 2.47 | 2.50 | 2.16 |
| Quick ratioi | 2.21 | 2.27 | 2.16 | 2.84 | 2.18 | 2.42 | 2.33 | 1.97 |
| Debt / assetsi | 40.94 | 38.55 | 33.96 | 31.33 | 31.29 | 31.18 | 30.14 | 31.80 |
| LT debt / equityi | 93.09 | 80.51 | 68.60 | 57.58 | 57.80 | 57.38 | 58.17 | 64.82 |
| Interest coveragei | 4.65 | 5.48 | 7.82 | 9.36 | 8.92 | 5.48 | 4.73 | 3.40 |
| Revenue CAGR (3Y) %i | 18.08 | 11.86 | 10.07 | 5.65 | 10.28 | 8.32 | 0.74 | -4.58 |
| Net income CAGR (3Y) %i | 17.32 | 21.58 | 8.30 | 37.49 | 15.35 | 3.07 | -24.67 | -24.91 |
| FCF CAGR (3Y) %i | 37.57 | 17.66 | 31.60 | -14.98 | -1.23 | 2.06 | 31.88 | 2.15 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.65 | 7.71 | 7.25 | 6.34 | 5.48 | 4.57 |
| ROA %i | 4.40 | 3.91 | 3.67 | 3.19 | 2.54 | 2.15 |
| ROIC %i | 6.65 | 6.29 | 6.08 | 5.51 | 4.58 | 4.20 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.97 | 6.47 | 6.23 | 5.79 | 5.31 | 4.86 |
| FCF / sales %i | 7.68 | 8.47 | 7.11 | 7.24 | 7.30 | 5.57 |
| Current ratioi | 2.37 | 2.11 | 1.99 | 2.16 | 2.10 | 2.13 |
| Quick ratioi | 2.32 | 1.91 | 1.81 | 1.97 | 1.92 | 1.98 |
| Debt / assetsi | 36.42 | 32.62 | 31.50 | 31.80 | 36.30 | 35.74 |
| LT debt / equityi | 74.01 | 66.33 | 63.59 | 64.82 | 81.72 | 79.67 |
| Interest coveragei | 4.51 | 4.02 | 3.77 | 3.40 | 3.05 | 2.69 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Commercial is the largest reported line at 69.68% of revenue, across 2 reported segments.
- Federal Government follows at 30.32%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Commercial69.68%
Federal Government30.32%
Quote time 2026-10-08 07:00:12 · For reference only, not investment advice and not tailored to your situation.